Skip to main content

Table 1 Summary of multiparametric CMR data at each timepoint.

From: Myocardial remodeling in reperfused myocardial infarction with multiparametric CMR: does diffuse fibrosis occur in remote noninfarcted myocardium?

 

Time point post-MI

 

Baseline

Day 2

Day 30

End-diastolic volume (ml)

54.7 ± 13.1

61.0 ± 11.0

70.4 ± 9.6*

End-systolic volume (ml)

22.7 ± 8.4

29.4 ± 8.3

38.6 ± 10.2*

Ejection fraction (%)

59.3 ± 7.4

52.0 ± 9.3

45.6 ± 10.4*

Infarct size (%)

-

21.7 ± 7.3

13.1 ± 4.6†

T2, noninfarcted (ms)

492 ± 44

484 ± 58

501 ± 109

T2, infarct (ms)

-

653 ± 57‡

670 ± 106‡

T1 pre, noninfarcted (ms)

895 ± 52

939 ± 23*

916 ± 26

T1 pre, infarct (ms)

-

1000 ± 54‡

1089 ± 30‡

T1 post, noninfarcted (ms)

486 ± 53

530 ± 61

491 ± 42.0

T1 post, infarct (ms)

-

327 ± 58‡

330 ± 46‡

λ, non-infarcted

0.37 ± 0.02

0.37 ± 0.03

0.39 ± 0.03

λ, infarct

-

0.967 ± 0.25‡

0.881 ± 0.13‡

  1. Data presented as mean ± SD. (λ = Partition Coefficient) * p-value < 0.05 vs. Baseline. † p-value < 0.05 vs. Day 2. ‡ p-value < 0.05 vs. non-infarcted myocardium at Baseline, Day 2 and Day 30.